Literature DB >> 15486635

Schistosomal hepatopathy.

Zilton A Andrade1.   

Abstract

Gross anatomical features and a complex set of vascular changes characterize schistosomal hepatopathy as a peculiar form of chronic liver disease, clinically known as "hepatosplenic schistosomiasis". It differs from hepatic cirrhosis, although clinical and pathological aspects may sometimes induce confusion between these two conditions. Intrahepatic portal vein obstruction and compensatory arterial hypertrophy render the hepatic parenchyma vulnerable to ischemic insult. This may lead to focal necrosis, which may give place to focal post-necrotic scars. These events are of paramount importance for the clinico-pathological evolution of schistosomal hepatopathy. Although portal fibrosis due to schistosomiasis sometimes reveals numerous myofibroblasts, it does not mean that such fibrosis belongs to a peculiar type. Damage to the muscular walls of the portal vein may be followed by dissociation of smooth muscle cells and their transition toward myofibroblasts, which appear only as transient cells in schistosomal portal fibrosis. Studies made with plastic vascular casts, especially those with the murine model of "pipestem" fibrosis have helped to reveal the mechanisms involved in systematized portal fibrosis formation. However, the factors involved in the pathogenesis of hepatosplenic disease remain poorly understood. A process of chronic hepatitis is a common accompaniment of portal fibrosis in schistosomiasis. Most of the times it is caused by concomitant viral infection. However, no special interaction seems to exist between schistosomal hepatopathy and viral hepatitis.

Entities:  

Mesh:

Year:  2004        PMID: 15486635     DOI: 10.1590/s0074-02762004000900009

Source DB:  PubMed          Journal:  Mem Inst Oswaldo Cruz        ISSN: 0074-0276            Impact factor:   2.743


  21 in total

1.  Increased Hepatic Arterial Blood Flow Measured by Hepatic Perfusion Index in Hepatosplenic Schistosomiasis: New Concepts for an Old Disease.

Authors:  Bernardo Times de Carvalho; Ana Lúcia Coutinho Domingues; Edmundo Pessoa de Almeida Lopes; Simone Cristina Soares Brandão
Journal:  Dig Dis Sci       Date:  2016-02-26       Impact factor: 3.199

2.  Schistosomiasis--An unusual cause of abdominal pseudotumor.

Authors:  Akintayo Oguntona Segun; Christopher Olutayo Alebiosu; A O J Agboola; A A F Banjo
Journal:  J Natl Med Assoc       Date:  2006-08       Impact factor: 1.798

Review 3.  Noncirrhotic portal hypertension.

Authors:  Harshal Rajekar; Rakesh K Vasishta; Yogesh K Chawla; Radha K Dhiman
Journal:  J Clin Exp Hepatol       Date:  2011-11-09

4.  Agressive inflammatory myofibroblastic tumor of the liver with underlying schistosomiasis: a case report.

Authors:  Vera Lucia Pannain; Juliana Vial Passos; Ariovaldo Rocha Filho; Cristiane Villela-Nogueira; Adriana Caroli-Bottino
Journal:  World J Gastroenterol       Date:  2010-09-07       Impact factor: 5.742

5.  Serum osteopontin is a biomarker of severe fibrosis and portal hypertension in human and murine schistosomiasis mansoni.

Authors:  Thiago Almeida Pereira; Wing-Kin Syn; Fausto E L Pereira; José Roberto Lambertucci; William Evan Secor; Anna Mae Diehl
Journal:  Int J Parasitol       Date:  2016-10-10       Impact factor: 3.981

6.  Coinfection with hepatitis C virus and schistosomiasis: fibrosis and treatment response.

Authors:  Mahasen Abdel-Rahman; Mohammad El-Sayed; Maissa El Raziky; Aisha Elsharkawy; Wafaa El-Akel; Hossam Ghoneim; Hany Khattab; Gamal Esmat
Journal:  World J Gastroenterol       Date:  2013-05-07       Impact factor: 5.742

7.  Macrophage-derived Hedgehog ligands promotes fibrogenic and angiogenic responses in human schistosomiasis mansoni.

Authors:  Thiago A Pereira; Guanhua Xie; Steve S Choi; Wing-Kin Syn; Izabela Voieta; Jiuyi Lu; Isaac S Chan; Marzena Swiderska; Kirsten B Amaral; Carlos M Antunes; William E Secor; Rafal P Witek; José R Lambertucci; Fausto L Pereira; Anna Mae Diehl
Journal:  Liver Int       Date:  2012-11-01       Impact factor: 5.828

8.  Abnormal liver function in different patients with Schistosoma japonicum.

Authors:  An Ning; Xiaoying Wu; Hongyu Li; Jinyi Liang; Zulu Gao; Jia Shen; Zhen Liu; Jun Xu; Fei Hu; Feng Wu; Pengyu Ji; Zhongdao Wu; Xi Sun
Journal:  Parasitol Res       Date:  2014-10-08       Impact factor: 2.289

9.  Value of α-smooth muscle actin and glial fibrillary acidic protein in predicting early hepatic fibrosis in chronic hepatitis C virus infection.

Authors:  Sohier Zakaria; Magdy Youssef; Mona Moussa; Maha Akl; Eman El-Ahwany; Maysa El-Raziky; Omaima Mostafa; Ahmed-Hazem Helmy; Ali El-Hindawi
Journal:  Arch Med Sci       Date:  2010-06-30       Impact factor: 3.318

10.  Schistosome-induced cholangiocyte proliferation and osteopontin secretion correlate with fibrosis and portal hypertension in human and murine schistosomiasis mansoni.

Authors:  Thiago A Pereira; Wing-Kin Syn; Mariana V Machado; Paula V Vidigal; Vivian Resende; Izabela Voieta; Guanhua Xie; Alba Otoni; Márcia M Souza; Elisângela T Santos; Isaac S Chan; Guilherme V M Trindade; Steve S Choi; Rafal P Witek; Fausto E Pereira; William E Secor; Zilton A Andrade; José Roberto Lambertucci; Anna Mae Diehl
Journal:  Clin Sci (Lond)       Date:  2015-07-21       Impact factor: 6.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.